RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- Operating income, 2025
- $1.6B
- YoY, 2025
- +20.7%
- 5-year CAGR
- −0.5%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $1.6B | +20.7% |
| 2024 | $1.3B | −13.4% |
| 2023 | $1.5B | +385.9% |
| 2022 | $307M | −78.5% |
| 2021 | $1.4B | −10.3% |
| 2020 | $1.6B | −39.2% |
| 2019 | $2.6B | +92.3% |
| 2018 | $1.4B | — |